Physician profile
Carolyn Stolte
NPI 1285241653
$5,256.02
in general payments reported to CMS, 2019-2025
19 companies · $5,204 in 2025
The $5,204 reported for 2025 was more than what 99% of Medical-Surgical (Registered Nurse) providers received nationally (typical 2025 total: $93.82).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $26.21 · 2024: $25.86 · 2025: $5,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,150 · Food and Beverage: $1,484 · Travel and Lodging: $510 · Education: $85.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,150.00 |
| Food and Beverage | $1,483.95 |
| Travel and Lodging | $510.00 |
| Education | $85.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eli Lilly and Company | $3,660.00 | 2025 | Ebglyss |
| Ucb, INC. | $225.94 | 2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $213.85 | 2025 | Dupixent |
| Galderma Laboratories, L.P. | $210.47 | 2025 | Nemluvio |
| Abbvie INC. | $202.06 | 2025 | |
| Genzyme Corporation | $184.38 | 2025 | |
| Amgen INC. | $147.40 | 2024-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $113.08 | 2025 | |
| Organon LLC | $72.50 | 2025 | Vtama |
| Lilly USA, LLC | $56.45 | 2022-2025 | Taltz, Ebglyss |
| Revance Therapeutics, INC. | $23.83 | 2025 | Daxxify |
| E.R. Squibb & Sons, L.L.C. | $21.62 | 2025 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $21.05 | 2025 | |
| Incyte Corporation | $18.72 | 2025 | Opzelura |
| Arcutis Biotherapeutics, INC. | $18.66 | 2025 | Zoryve |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $18.51 | 2025 | Anzupgo |
| Pfizer INC. | $16.67 | 2025 | |
| Lnhc, INC | $16.33 | 2025 | Zelsuvmi |
| Merck Sharp & Dohme LLC | $14.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolyn Stolte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.